Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

(2020) Salim S. Virani et al.   CIRCULATION

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke

(2020) Bruce C. V. Campbell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions

(2020) Aristeidis H. Katsanos et al.   STROKE

Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis

(2020) M. Oliveira et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

(2019) William J. Powers et al.   STROKE

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

(2018) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials

(2018) Babikir Kheiri et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

(2017) Nicola Logallo et al.   LANCET NEUROLOGY

The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care

(2017) Cora H Ormseth et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study

(2015) Xuya Huang et al.   LANCET NEUROLOGY

Forecasting the Future of Stroke in the United States: A Policy Statement From the American Heart Association and American Stroke Association

(2013) B. Ovbiagele et al.   STROKE

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

(2012) Mark Parsons et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke

(2010) E. Clarke Haley et al.   STROKE

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE